Lepidic Type Lung Adenocarcinoma Masquerading as Chronic Infectious Pneumonia: A Case Report

Authors

  • Abid Ullah Department of Medicine, Bacha Khan Medical Complex, Swabi - Pakistan
  • Kiran Naz Department of Medicine, Bacha Khan Medical Complex, Swabi - Pakistan
  • Amina Akbar Department of Medicine, Bacha Khan Medical Complex, Swabi - Pakistan

Keywords:

Lepidic Adenocarcinoma, Bronchioloalveolar Carcinoma, Nonresolving Pneumonia, Pakistan

Abstract

Background:Lepidic-type adenocarcinoma (previously known as bronchioloalveolar carcinoma) represents a unique subtype of lung adenocarcinoma that is characterized by the growth of atypical epithelial cells along pre-existing alveolar structures without evidence of stromal, vascular, or pleural invasion. Its radiographic presentation often overlaps with chronic infections like tuberculosis or fungal disease, which can lead to delays in diagnosis, particularly in endemic areas. Case Presentation:We report the case of a 58-year-old, nonsmoking woman from Swabi, Pakistan, who presented to our institution with progressive shortness of breath, productive cough, chest pain, and constitutional symptoms over two months. She had a history of herpes zoster infection and received empiric antituberculous treatment. Chest radiography demonstrated bilateral patchy opacities and cystic lesions. Multiple sputum studies, GeneXpert, and fungal culture studies were negative for infectious etiologies. Computed tomography demonstrated bilateral multiple consolidations with cavitary nodules and minimal pleural effusion. Bronchoscopic evaluation with transbronchial lung biopsy revealed findings consistent with lung adenocarcinoma, lepidic pattern. Conclusion:When considering individuals with non-resolving pneumonia, especially in patients undergoing infection treatments, the diagnosis of lepidic adenocarcinoma should be given consideration. Early histopathologic diagnosis is important for accurate diagnosis and management, ideally through bronchoscopy and/or lung biopsy.

References

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. DOI:10.3322/caac.21660

Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International, multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244–285. DOI:10.1097/JTO.0b013e318206a221

Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed. Lyon: IARC; 2015.

Kirby M, Pike D, Coxson HO, McCormack DG, Parraga G. Mucinous versus nonmucinous lepidic predominant invasive adenocarcinoma of the lung: CT and histopathologic comparisons. Radiology. 2015;274(1):285–296. DOI:10.1148/radiol.14140161

Rehman AU, Shafiq F, Anosh M, Naz S, Kamran N, Ali K. Strategies for Patients with newly Diagnosed Oral Squamous Cell Carcinoma and a Positive Chest CT. Pak J Chest Med. 2022;28(3):339-44.

Oikonomou A, Hansell DM. Organizing pneumonia: the many morphological faces. Eur Radiol. 2002;12(6):1486–1496. DOI:10.1007/s00330-001-1228-9.

Lee JH, Yum HK, Jamous F, Santos C, Campisi A, Surani S, et al. Diagnostic procedures and clinico-radiological findings of acute fibrinous and organizing pneumonia: a systematic review and pooled analysis. Eur Radiol. 2021;31(10):7283-94. DOI:10.1007/s00330-021-07868-z.

Henschke CI, Yankelevitz DF, Yip R, Reeves AP, Farooqi A, Xu D, et al. Lung cancers diagnosed at annual CT screening: volume doubling times. Radiology. 2012;263(2):578–583. DOI:10.1148/radiol.12102489

Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MG, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for therapy. Mod Pathol. 2011;24(5):653–64. DOI:10.1038/modpathol.2010.232

Kim J, Lee KS, Krauss DJ, Nadelman CM, Johnson M, Park JS, et al. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant invasive adenocarcinoma in stage I lung cancer. J Thorac Oncol. 2014;9(12):1860–68. DOI:10.1097/JTO.0000000000000369

Noguchi M. Predictive factors for recurrence of adenocarcinoma of the lung: pathology viewpoints. Pathol Int. 2005;55(11):665–73. DOI:10.1111/j.1440-1827.2005.01844.x

Russell PA, Wainer Z, Wright GM, Daniels M, Conron M, Williams RA, et al. Prognostic significance of the IASLC/ATS/ERS classification of lung adenocarcinoma in a large North American cohort. J Thorac Oncol. 2011;6(9):1496–504. DOI:10.1097/JTO.0b013e318225954c

Liu Y, Yang J, Liu X, Zhang X, Chen L, Li W, et al. Intratumor heterogeneity predicts prognosis in lepidic predominant lung adenocarcinoma. Thorac Cancer. 2025;16(3):490–97. DOI:10.1111/1759-7714.14455

Downloads

Published

2025-06-02

How to Cite

Ullah, A. ., Naz, K., & Amina Akbar. (2025). Lepidic Type Lung Adenocarcinoma Masquerading as Chronic Infectious Pneumonia: A Case Report. Pakistan Journal of Chest Medicine, 31(2), 164–169. Retrieved from http://pjcm.net/index.php/pjcm/article/view/1046

Issue

Section

Case Report